- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03293199
Comparing Efficacy of Chest Tube Drainage and Needle Aspiration in Pneumothorax Treatment
Randomized Controlled Trial on Comparison of Chest Tube Drainage and Needle Aspiration in Treatment of Spontaneous Pneumothorax
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The chest tube drainage and needle aspiration are widely used first step techniques in spontaneous pneumothorax, thus present randomized controlled trial (RCT) aims to compare the efficacy of abovementioned techniques, as well as long-term outcomes. The study protocol has been confirmed by the ethics committee of AJA University. In current multi-center single-blinded RCT, all patients admitted with primary spontaneous pneumothorax will be enrolled study and written consent form provided by patients, simultaneously. With due attention to the success rate of 18% provided in a previous study comparing primary spontaneous pneumothorax treatment procedures and the study power of 80% and the confidence coefficient of 0.05, study population calculated to include 64 patient, which increased to 70 patients with taking 10% of falling risk into consideration. Using Randlist software, patients will be randomly assigned to study groups including (A) chest tube drainage and (B) needle aspiration. Subsequently, all patients will undergo one-year follow-up and will be evaluated in terms of treatment success rate and pneumothorax recurrence.
In chest tube drainage group, while the patient is positioned in the supine position and subsequent to local anesthesia administration via lidocaine 2%, F16 or F20 (based on patients physical status) sterile plastic tube will be implemented at the level 4th or 5th intercostal space through the midaxillary line. However, in needle aspiration group, patients will be positioned semi-supine. Subsequently, G16 intravenous angiocath will be inserted through the midclavicular line at the level 2nd or 3rd intercostal space. The catheter needle will be removed and catheter will be fixed using sterile sticks. A three-way valve will be connected to the external end of the catheter and a 50 ml syringe will be connected to the valve. The air suction will be performed using 50 ml syringe till end of the air suction or up to 3.5 liters of air suctioning.
Hypothesis of present trial are as follows: a) repetitive needle aspiration may lead to higher treatment success rate in patients with primary spontaneous pneumothorax, in comparison to chest tube drainage, b) needle aspiration may result in reduction of hospital admission duration in patients with primary spontaneous pneumothorax compared to chest tube drainage, c) the rate of spontaneous pneumothorax recurrence during one-year follow-up might be lower in patients who undergo needle aspiration instead of chest tube drainage.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
East Azerbaijan
-
Tabriz, East Azerbaijan, Iran, Islamic Republic of
- Recruiting
- Imam Reza Hospital
-
Contact:
- Seyed Ziaeddin Rasihashemi, Professor
- Phone Number: +989144126652
- Email: zia.hashemi@yahoo.com
-
Principal Investigator:
- Ali Ramouz
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Aged more than 18 years old
- Symptomatic primary spontaneous pneumothorax or intervention-needed spontaneous pneumothorax (pneumothorax more than 20% in volume due to Light criteria)
Exclusion Criteria:
- Tension pneumothorax
- bilateral severe respiratory failure
- demand for mechanical ventilation
- bilateral pneumothorax
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Chest tube drainage
This group will undergo chest tube drainage as an intervention for spontaneous pneumothorax treatment.
|
In this group, in the supine position and subsequent to prepping and draping and local anesthesia administration via lidocaine 2%, F16 or F20 (based on patients physical status) sterile plastic tube will be implemented at the level 4th or 5th intercostal space through the midaxillary line.
Subsequently, the external end of the tube will be connected to water sealing bottle and water bubbles coming out will be considered as proper chest tube insertion.
|
|
Active Comparator: Needle aspiration
This group will undergo repetitive needle aspiration as an intervention for spontaneous pneumothorax treatment.
|
In this group, prior to needle aspiration, patients will take the semi-supine position.
Subsequent to local anesthesia via lidocaine 2%, as well as prepping and draping, G16 intravenous angiocath will be inserted through midclavicular line at the level 2nd or 3rd intercostal space.
Air bubble inside the lidocaine syringe will be considered as needled entrance to pleural cavity, thus 5-10 cm of the angiocath will be import to inside of the cavity.
The catheter needle will be removed and catheter will be fixed using sterile sticks.
A three-way valve will be connected to external end of the catheter and a 50 ml syringe will be connected to the valve.
The air suction will be performed using 50 ml syringe till end of the air suction or up to 3.5 liters of air suctioning.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pneumothorax recurrence during one-year
Time Frame: One year postoperative
|
Will be defined as the rate of pneumothorax recurrence until postoperative one-year.
|
One year postoperative
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Successful treatment rate
Time Frame: Postoperative day 1 and postoperative day 7
|
Is defined as completely resolved pneumothorax during admission.
|
Postoperative day 1 and postoperative day 7
|
|
Length of hospital admission
Time Frame: Through hospital admission, an average of 10 days
|
will be calculated from the time of the operation to time of discharge.
|
Through hospital admission, an average of 10 days
|
|
Operation time
Time Frame: During procedure
|
Will be calculated from the time of skin incision to completing the procedure including complete chest tube insertion in chest tube group or complete air suction or up to 3.5 liters of air suction in needle aspiration group.
|
During procedure
|
|
Procedure induced complications
Time Frame: Postoperative day 1, Postoperative day 3, Postoperative day 7, Postoperative month 1,
|
Includes all complications occurred during or after procedure during hospital stay.
|
Postoperative day 1, Postoperative day 3, Postoperative day 7, Postoperative month 1,
|
|
Pneumothorax size
Time Frame: Before procedure, 1 hour after procedure, 48 hours after procedure, one-week after procedure
|
Will be calculated by Light's formula using chest radiography
|
Before procedure, 1 hour after procedure, 48 hours after procedure, one-week after procedure
|
Collaborators and Investigators
Collaborators
Publications and helpful links
General Publications
- MacDuff A, Arnold A, Harvey J; BTS Pleural Disease Guideline Group. Management of spontaneous pneumothorax: British Thoracic Society Pleural Disease Guideline 2010. Thorax. 2010 Aug;65 Suppl 2:ii18-31. doi: 10.1136/thx.2010.136986. No abstract available.
- Tschopp JM, Marquette CH. Spontaneous pneumothorax: stop chest tube as first-line therapy. Eur Respir J. 2017 Apr 12;49(4):1700306. doi: 10.1183/13993003.00306-2017. Print 2017 Apr. No abstract available.
- Hu X, Cowl CT, Baqir M, Ryu JH. Air travel and pneumothorax. Chest. 2014 Apr;145(4):688-694. doi: 10.1378/chest.13-2363.
- Cran IR, Rumball CA. Survey of spontaneous pneumothoraces in the Royal Air Force. Thorax. 1967 Sep;22(5):462-5. doi: 10.1136/thx.22.5.462.
- Harvey J, Prescott RJ. Simple aspiration versus intercostal tube drainage for spontaneous pneumothorax in patients with normal lungs. British Thoracic Society Research Committee. BMJ. 1994 Nov 19;309(6965):1338-9. doi: 10.1136/bmj.309.6965.1338. No abstract available.
- Dzeljilji A, Rokicki W, Rokicki M, Karus K. New aspects in the diagnosis and treatment of primary spontaneous pneumothorax. Kardiochir Torakochirurgia Pol. 2017 Mar;14(1):27-31. doi: 10.5114/kitp.2017.66926. Epub 2017 Mar 31.
- Thelle A, Gjerdevik M, SueChu M, Hagen OM, Bakke P. Randomised comparison of needle aspiration and chest tube drainage in spontaneous pneumothorax. Eur Respir J. 2017 Apr 12;49(4):1601296. doi: 10.1183/13993003.01296-2016. Print 2017 Apr.
- Tschopp JM, Bintcliffe O, Astoul P, Canalis E, Driesen P, Janssen J, Krasnik M, Maskell N, Van Schil P, Tonia T, Waller DA, Marquette CH, Cardillo G. ERS task force statement: diagnosis and treatment of primary spontaneous pneumothorax. Eur Respir J. 2015 Aug;46(2):321-35. doi: 10.1183/09031936.00219214. Epub 2015 Jun 25.
- Wakai A, O'Sullivan RG, McCabe G. Simple aspiration versus intercostal tube drainage for primary spontaneous pneumothorax in adults. Cochrane Database Syst Rev. 2007 Jan 24;(1):CD004479. doi: 10.1002/14651858.CD004479.pub2.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IR.AJAUMS.REC.1396.24
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pneumothorax, Spontaneous
-
Rennes University HospitalRecruiting
-
Peking University Third HospitalNot yet recruitingPrimary Spontaneous Pneumothorax
-
University Hospital, Strasbourg, FranceRecruiting
-
Chinese University of Hong KongRecruitingPneumothorax, SpontaneousHong Kong
-
Ain Shams UniversityRecruitingPrimary and Secondary Spontaneous PneumothoraxEgypt
-
University of Health Sciences LahoreNot yet recruitingPleural Effusion, Malignant | Pleurodesis | Pneumothorax Spontaneous Secondary | Pneumothorax Spontaneous PrimaryPakistan
-
Postgraduate Institute of Medical Education and...UnknownPrimary Spontaneous Pneumothorax | Malignant Pleural Effusions | Recurrent Pleural Effusions | Secondary Spontaneous PneumothoraxIndia
-
Zagazig UniversityUnknown
-
University Hospital, Strasbourg, FranceNot yet recruitingQuality of Life | Ambulatory Care | Primary Spontaneous Pneumothorax | Chest TubeFrance
-
Sohag UniversityRecruitingSpontaneous PneumothoraxEgypt
Clinical Trials on Chest tube drainage
-
Peking University Third HospitalNot yet recruitingPrimary Spontaneous Pneumothorax
-
University Hospital, Basel, SwitzerlandPfizer; Lancardis FoundationTerminatedComplicated Parapneumonic Effusion | Pleural EmpyemaGreece, Italy, Switzerland
-
Centre Hospitalier Universitaire de BesanconHospices Civils de Lyon; University Hospital, Angers; University Hospital, Rouen and other collaboratorsCompleted
-
National Taiwan University HospitalDepartment of Health, Executive Yuan, R.O.C. (Taiwan)Unknown
-
University of PennsylvaniaCLR MedicalRecruiting
-
Taipei Medical University HospitalNational Science Council, TaiwanUnknown
-
Guangdong Provincial People's HospitalUnknown
-
Corporacion Parc TauliNot yet recruitingPrimary Spontaneous Pneumothorax (PSP) | Conservative Management (Active Observation)
-
Xueying YangUnknown
-
University of California, IrvineCompletedCoronary Artery Disease | Heart Valve DiseaseUnited States